Ending chemotherapy induced hair loss.
Ending chemotherapy induced hair loss.
47% OF PATIENTS SAY HAIR LOSS IS THE MOST TRAUMATIC PART OF CANCER TREATMENT.
Luminate Medical has developed a novel device to prevent hair loss during chemotherapy. The unique portable, comfortable and wearable solution allows patients to maintain their confidence and dignity during treatment.
Hair loss is one of the most well recognised side effects of chemotherapy, affecting millions of cancer patients annually. Luminate Medical is dedicated to providing a patient-focused alternative.
News
February 18, 2021
Luminate Medical joins Y Combinator S21 Batch
Luminate Medical has received the backing of world-renowned technology accelerator Y Combinator to continue developing its novel...
December 31, 2020
Hannon announced as Thiel Fellowship recipient
The Thiel Foundation today named 24 people into the 2020 class of Thiel Fellows. The Fellowship program, which launched in 2011, encourages...
February 18, 2021
EIT Health Catapult Semi Finalists Announced
Forty-two start-ups have selected from across Europe for the EIT Health Catapult Semi-finals. The start-ups will receive intensive training from...
July 14, 2019
Medical device aims to curb chemo hair loss
At just 20 years of age, Mayo native Aaron Hannon is already in the throes of launching his second medical device venture...
February 18, 2021
A solution to chemo hair loss and more innovations
Covid may have ramped up the challenges of getting a new business going, but it hasn’t dampened the drive of five young entrepreneurs...
May 6, 2019
Device to stop chemo hair loss selected for CRAASH
10 international projects have been chosen to participate in the 2nd edition of CRAASH Barcelona, the acceleration program...
Our Team
Aaron Hannon
CEO
Dr Bárbara Oliveira
CTO
Prof Martin O'Halloran
CSO
Dr Patricia Smith
Chairperson
Prof Aoife Lowery
CMO
Jason
Costello
Product Design
Dr Alanna
Stanley
Anatomy